Boston Scientific, Inc. BSX recently obtained a CE Mark on the Vercise Neural Navigator 5 Software with STIMVIEW XT technology. When used as an element of the Vercise Genus Deep Brain Stimulation (DBS ...

The US Food and Drug Administration (FDA) has approved a new software upgrade for Abbott's Infinity deep-brain stimulation (DBS) system used in patients with Parkinson's disease and essential tremor, ...

Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...

Credit: Abbott. Liberta RC DBS is the smallest rechargeable DBS device featuring the NeuroSphere Virtual Clinical, which allows for remote programming capabilities. The Food and Drug Administration ...

Abbott has received U.S. Food & Drug Administration approval to launch a deep brain stimulation system (DBS) that the company touts as the world's smallest rechargeable device of its kind, the medical ...

This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing "This is the only directional lead with built-in sensing capabilities," said Jens Volkmann, ...

Please provide your email address to receive an email when new articles are posted on . The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s ...